MaxiVAX
Chemicals & Related Products · Switzerland · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Park Ave De Sécheron 15, Geneva, Geneva,...Phone Number
+41 225522613Website
www.maxivax.chRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About MaxiVAX
MaxiVAX, a Swiss clinical-stage biotech company developing novel anti-cancer vaccines, and Minaris Regenerative Medicine, a contract development and manufacturing service provider (CDMO) for the cell and gene therapy industry, have entered into a manufacturing agreement for MVX-ONCO-2, a cell-based immunotherapy for the treatment of cancers such as chordoma, head and neck, and other solid tumours.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is MaxiVAX your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at MaxiVAX
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when MaxiVAX launches new products
Earning: See what the market has to say on MaxiVAX recently announced quarterly report
Website visits: Recent activity has been detected on your website
Click to see if MaxiVAX had a recent Job posting/layoffs
MaxiVAX, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if MaxiVAX is spiking on competitors!
Funding: Get notified immidiatlly once MaxiVAX has new funding data
Check if MaxiVAX has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
MaxiVAX is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
MaxiVAX is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about MaxiVAX.
MaxiVAX Tech Stack
A closer look at the technologies used by MaxiVAX
MaxiVAX News & Media
Release Therapeutics Announces New CEO to Drive Best-in-Class CNS Innovation
Release Therapeutics Announces New CEO to drive strategic pivot towards treating genetic disorders of the CNS without gene therapyMaxiVAX and Minaris strike immunotherapy manufacturing deal
CDMO Minaris will be responsible for the GMP manufacturing, freezing and shipping of the MVX-ONCO-2 capsules, which will be delivered to clinical sites.
Read more news
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding MaxiVAX
Sign Up For FreeTo access detailed company insights
MaxiVAX, a Swiss clinical-stage biotech company developing novel anti-cancer vaccines, and Minaris Regenerative Medicine, a contract development and manufacturing service provider (CDMO) for the cell and gene therapy industry, have entered into a manufacturing agreement for MVX-ONCO-2, a cell-based immunotherapy for the treatment of cancers such as... Read More
